Skip to main content
. 2015 Sep-Oct;112(5):366–372.

Figure 2.

Figure 2

A and B: Posterior and lateral views of a tandem and ovoid implant. C. Coronal representations of an radiation plan delivering 45 Gy to the pelvic lymph nodes (red contour), and 20 Gy to the metabolically active primary cervical tumor (white contour) in a patient with FIGO stage IIb squamous cell carcinoma with pelvic lymph node involvement. D: Coronal isodose lines for a tandem and ovoid implant. The prescription isodose line is seen in green (650 cGy). E and F: Corresponding T2-weighted sagittal brachytherapy planning image with primary tumor in red (left), and corresponding diffusion-weighted sequence (right).